Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.4.0.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities    
Net loss $ (1,576) $ (6,580)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 20 $ 19
Amortization of debt discount 961
Amortization of deferred financing fees $ 85
Amortization of intangible assets $ 32
Non-cash financing expense $ 14
Loss on extinguishment of convertible debt $ 74
Change in fair value of warrants and derivative liability (2,459)
Change in fair value of share-settled debt (20)
Common stock issued for services 218 $ 106
Stock-based compensation expense 161 488
Changes in assets and liabilities:    
Prepaid expenses and other current assets 225 (62)
Accounts payable and accrued expenses (304) $ (1,851)
Related party liabilities and accrued interest 1
Accrued interest 127 $ 29
Net cash used in operating activities $ (2,487) (7,805)
Cash flows from investing activities    
Acquisition of DioGenix, Inc, net of non-cash portion $ (900)
Investment in convertible note receivable $ (500)
Acquisition other assets $ (1)
Net cash used in investing activities $ (500) (901)
Cash flows from financing activities    
Proceeds from senior secured convertible promissory notes 2,850
Repayment of notes payable $ (100) 0
Legal fees related to stock financing $ (91) (19)
Proceeds from issuance of common stock 2,820
Net cash provided by financing activities $ 2,911 8,601
Net increase in cash and cash equivalents (76) (105)
Cash and cash equivalents, beginning of the year 176 214
Cash and cash equivalents, end of period 100 $ 109
Supplemental schedule of non-cash investing and financing activities:    
Reclass Series E convertible preferred stock to temporary equity 8,764
Beneficial conversion feature of Series H convertible preferred stock 610
Deemed dividends related to immediate accretion of beneficial conversion feature of Series H convertible preferred stock 610
Fair Value of derivative liability common stock warrant issued with Series H convertible preferred stock 1,456
Series H preferred stock issued for note conversion 100
Debt discount associated with convertible promissory note - derivative liability 105
Reversal of unamortized debt discount related to debt conversion (35)
Common stock issued for accrued interest conversion 75
Common stock issued for share-settled debt and convertible promissory notes conversion 125
Reclass between notes payable and senior convertible notes $ 300
Common stock issued as fee for debt financing arrangement $ 102
Series E Convertible Preferred Stock [Member]    
Cash flows from financing activities    
Sale of preferred stock $ 230 $ 2,950
Repurchase of preferred stock (384)
Supplemental schedule of non-cash investing and financing activities:    
Common stock issued in conversion of preferred stock 1,205 $ 172
Deemed dividends on conversion of preferred stock to common stock 130
Deemed dividends on repurchase of preferred stock 27
Deemed dividends related to accretion of preferred stock redemption value 3,137
Series H Convertible Preferred Stock [Member]    
Cash flows from financing activities    
Sale of preferred stock 3,890
Repurchase of preferred stock (634)
Supplemental schedule of non-cash investing and financing activities:    
Common stock issued in conversion of preferred stock 1,354
Deemed dividends on conversion of preferred stock to common stock 923
Deemed dividends on repurchase of preferred stock 48
Deemed dividends related to accretion of preferred stock redemption value $ 5,095
Series D preferred stock dividend [Member]    
Supplemental schedule of non-cash investing and financing activities:    
Common stock issued in conversion of preferred stock $ 9
Stock issued for preferred quarterly dividend 35
Series preferred stock dividend accrued 15
Series E preferred stock dividend [Member]    
Supplemental schedule of non-cash investing and financing activities:    
Stock issued for preferred quarterly dividend $ 325 237
Series preferred stock dividend accrued 601 $ 192
Series H preferred stock dividend [Member]    
Supplemental schedule of non-cash investing and financing activities:    
Stock issued for preferred quarterly dividend 148
Series preferred stock dividend accrued $ 148